Researchers in Brazil are testing a 'cocaine vaccine' aimed at reducing the euphoria associated with the use of this drug and consequently the desire to consume it. According to Brazilian researchers, this vaccine encourages the body to produce antibodies that attach to cocaine upon entering the bloodstream, preventing the drug from reaching the brain. The researchers express satisfaction with the results of the vaccine injections, stating that the cocaine vaccine alone is not effective and must be accompanied by psychotherapy and therapy. On the other hand, some experts warn that if after vaccination, cocaine consumption does not have the previous effect, the addicted person may turn to higher doses and face a greater risk of overdose. Other experts believe that addiction to cocaine is not solely related to its consumption, and the physical and psychological damages after quitting addiction also require treatment. Therefore, vaccination will only be suitable for a small number of individuals who are simultaneously undergoing specialized treatments and will not help addicts who do not have access to counseling and treatment. United Nations estimates indicate that in 2021, about 22 million people worldwide were cocaine users, and in Europe, this drug ranked second in prevalence after cannabis. Cocaine creates a high dependency due to dopamine secretion in the brain, causing serious damage to body organs and leaving effects similar to running a marathon, with withdrawal accompanied by severe physical and psychological pressure. This week’s sponge; cocaine addiction, childhood abduction, and rape, interest in older men. Behind the scenes - fentanyl threat. The President of Ecuador declared war on drug gangs. The United States accused 8 Chinese companies and 12 individuals in connection with the 'fentanyl crisis in America.' Czech police discovered 646 kilograms of cocaine among Ecuadorian banana shipments. Italian police seized a cocaine shipment worth $946 million.
Brazilian Researchers' Efforts to Create Cocaine Vaccine; Goal: Reduce Euphoria from Use
Brazilian researchers are developing a vaccine to reduce the euphoric effects of cocaine use, but caution that it should be combined with therapy. Experts warn that without proper treatment, users may seek higher doses, increasing overdose risks. The issue highlights the complexities of addiction treatment and the global cocaine crisis.
👥 Key Players
⚡ Actions
📰 What Happened
Brazilian researchers develop a cocaine vaccine to reduce drug euphoria and consumption desire.
- Brazilian researchers announce cocaine users
- experts warn addicted individuals
- United Nations state cocaine users
💡 Why It Matters
📚 Background
The development of a cocaine vaccine could significantly impact addiction treatment but poses risks of increased overdose.
📝 Key Evidence
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%